Perceptions and prescribing considerations among US psychiatrists regarding drug-drug interactions associated with oral atypical antipsychotics.
Frois
Christian
C
Analysis Group, Inc, Boston, MA, USA. cfrois@analysisgroup.com
Guerin
Annie
A
Saraogi
Amit
A
Panish
Jessica
J
Dirani
Riad
R
D000284:Administration, Oral; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D001364:Awareness / Q000502:physiology; D003625:Data Collection; D004347:Drug Interactions; D016903:Drug Monitoring / Q000706:statistics & numerical data; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology / Q000209:etiology / Q000473:pathology; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D057970:Inappropriate Prescribing / Q000523:psychology / Q000706:statistics & numerical data*; D015994:Incidence; D010465:Perception / Q000502:physiology; D011361:Professional Competence; D011570:Psychiatry; D012720:Severity of Illness Index; D014481:United States
D014150:Antipsychotic Agents